Abstract
Malaria is a severe, life-threatening infectious disease that endangers human health. However, there are no vaccines or immune strategy of vaccines succeeding in both erythrocytic and pre-erythrocytic stage. During the liver stage of the Plasmodium life cycle, sporozoites invade the host liver cells. The sporozoites, then, induce a cellular immune response via the major histocompatibility complex (MHC) molecules on their surfaces. The cytotoxic T lymphocytes (CTLs) then recognize the corresponding antigen-MHC complex on the surfaces of these infected liver cells and kill them. However, dominant epitopes with high MHC affinity are prone to mutation due to immune selection pressure. CTLs evoked by the original dominant epitopes cannot recognize the mutated epitopes, leading to immune evasion. In this study, we have modified the cryptic epitopes of different antigens in the sporozoite and liver stages of Plasmodium falciparum to increase their immunogenicity without changing T cell antigen receptor (TCR)-peptide binding specificity. In addition, we have also added an important erythrocytic phase protective antigen, named apical membrane antigen 1 (AMA-1), to this process with the goal of constructing a complex multi-stage, multi-e...Continue Reading
References
Apr 4, 2002·The Journal of Infectious Diseases·Stephen L HoffmanThomas L Richie
Dec 8, 2004·Nature·Ann-Kristin MuellerKai Matuschewski
Feb 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ann-Kristin MuellerStefan H I Kappe
Jun 30, 2006·Vaccine·Jun MiaoLiwang Cui
May 2, 2007·Current Opinion in Infectious Diseases·Bernard N Kanoi, Thomas G Egwang
Apr 21, 2009·Molecular and Biochemical Parasitology·Thomas J Templeton
Nov 16, 2010·Annales pharmaceutiques françaises·J CohenA Leach
Mar 3, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Fatin Nawwab Al-DeenRoss Coppel
Mar 26, 2011·Trends in Parasitology·Robert J Schwenk, Thomas L Richie
Aug 6, 2011·Malaria Journal·Amanda LeachUNKNOWN Clinical Trials Partnership Committee
Oct 18, 2011·PloS One·Cindy TammingaThomas L Richie
Oct 20, 2011·The New England Journal of Medicine·UNKNOWN RTS,S Clinical Trials PartnershipPreeti Vansadia
Nov 10, 2012·The New England Journal of Medicine·UNKNOWN RTS,S Clinical Trials PartnershipPreeti Vansadia
Jan 22, 2013·Journal of Virological Methods·Xiao-Jun HuangZhi-Kai Xu
Mar 5, 2013·Molecular Biology Reports·Yinghui LiYa Zhao
Mar 5, 2013·PloS One·Ilin ChuangThomas L Richie
Aug 1, 2013·Human Vaccines & Immunotherapeutics·Cindy TammingaThomas L Richie
Oct 12, 2013·Malaria Journal·Geoffrey A T TargettGraham V Brown
Nov 6, 2013·Parasite Immunology·J B de Souza
Mar 19, 2014·Journal of Internal Medicine·C Arama, M Troye-Blomberg
Jul 30, 2014·PLoS Medicine·UNKNOWN RTS,S Clinical Trials Partnership
Aug 27, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susanne H HodgsonSimon J Draper
Sep 10, 2014·International Journal for Parasitology·Denise L DoolanCarla Proietti
Sep 10, 2014·Vaccine·Johannes PfeilSteffen Borrmann
Sep 12, 2014·PloS One·Martha SedegahThomas L Richie
Sep 24, 2014·PloS One·Amy R NoeGabriel M Gutierrez